Abdel Mazouzi
@amazouzi.bsky.social
580 followers
440 following
21 posts
Scientist at the Netherlands Cancer Institute, EMBO fellow, Opinions are my own
Posts
Media
Videos
Starter Packs
Pinned
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
Reposted by Abdel Mazouzi
Reposted by Abdel Mazouzi
Abdel Mazouzi
@amazouzi.bsky.social
· Sep 4
Reposted by Abdel Mazouzi
Reposted by Abdel Mazouzi
Reposted by Abdel Mazouzi
Reposted by Abdel Mazouzi
Sarah Moser
@sarahmoser.bsky.social
· Aug 13
NASP modulates histone turnover to drive PARP inhibitor resistance - Nature
PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
www.nature.com
Reposted by Abdel Mazouzi
Sarah Moser
@sarahmoser.bsky.social
· Aug 13
Reposted by Abdel Mazouzi
Sarah Moser
@sarahmoser.bsky.social
· Aug 13
NASP modulates histone turnover to drive PARP inhibitor resistance - Nature
PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
www.nature.com
Reposted by Abdel Mazouzi
Craig Kaplan
@triggerloop.bsky.social
· Aug 13
Sarah Moser
@sarahmoser.bsky.social
· Aug 13
NASP modulates histone turnover to drive PARP inhibitor resistance - Nature
PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
www.nature.com
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 14
Reposted by Abdel Mazouzi
Barbara Marte
@barbmarte.bsky.social
· Aug 14
NASP modulates histone turnover to drive PARP inhibitor resistance - Nature
PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
www.nature.com
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
NASP modulates histone turnover to drive PARP inhibitor resistance
Nature - PARP inhibitor treatment triggers histone release from the chromatin in cancer cells; consequently, targeting the histone chaperone NASP renders cells vulnerable to PARP inhibition.
rdcu.be
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
Abdel Mazouzi
@amazouzi.bsky.social
· Aug 13
Reposted by Abdel Mazouzi
Reposted by Abdel Mazouzi
Abdel Mazouzi
@amazouzi.bsky.social
· Mar 21
SRBD1, a highly conserved gene required for chromosome individualization | Jonne Raaijmakers
Excited to share our latest publication in Cell Reports!
Our study reveals the critical role of SRBD1, a highly conserved and previously enigmatic essential…
www.linkedin.com